Newsletter | March 26, 2025

03.26.25 -- A Genetic Medicine Approach To ALS

FEATURED PODCAST

BoB@JPM: Kasper Roet, Ph.D., QurAlis

On this episode of the Business of Biotech, Life Science Leader's Ben Comer joins to co-host a conversation with Dr. Roet that goes deep on his company's genetic medicine approach to ALS, and even deeper into his opinions on, and growing influence over, the regulatory environment.

INDUSTRY INSIGHTS

Leveraging Multiple Data Sources For Comprehensive Insights

Discover how integrating internal and external data can enhance decision-making and efficiency, how to manage diverse data sources, and the benefits of a single source of truth for your organization.

Tips And Tricks For Developing Rare Cancer Clinical Trials

Conducting clinical trials for rare cancers presents unique challenges, making a partnership with an experienced oncology CRO crucial for overcoming hurdles and ensuring trial success.

Outlook 2025: Key Trends And Insights

Dive into the key trends and challenges shaping the year ahead, from geopolitical uncertainties to cutting-edge innovation in AI, oncology, and weight-loss therapies.

The Future Of Clinical Research Enrollment

To address challenges such as limited patient awareness, mistrust, and logistical barriers, the industry must embrace technology-driven solutions and community-centered outreach.

Nitrosamine Impurities Deadline: Are Your Products Compliant?

Learn how to select an experienced nitrosamine mitigation provider and how a tailored, quantified strategy can help you bring your product into compliance while maintaining control of the process.